✈️🇬🇧 London, here we go!
The ZLAB team is heading to #AAIC26, the world's largest conference on Alzheimer's disease and dementia. Proud to share research from 🇧🇷🧠
Our presentations: https://t.co/JnXUGuU0gQ
@alzassociation@erzimmer
Tau PET is central to Alzheimer's diagnosis and trial selection. But does tracer choice matter? The HEAD study set out to answer that. 682 participants, both Flortaucipir and MK6240, across the Alzheimer's spectrum. Out today in @TheLancet.
Article link: https://t.co/BUCVevtJJ0
🚨Just published in @NatureNeuro🚨
Led by @jpfsouza33, this study used imaging & fluid biomarkers to reveal that microglia modulate Aβ-related astrocyte reactivity, which in turn contributes to Alzheimer’s disease progression.
🔗 https://t.co/MNvJtYY41B
✈️🇨🇦 Toronto, here we go! The ZLAB team is heading to #AAIC2025, the world’s largest conference on AD and dementia. 5 days of science, learning and a chance to showcase research made in 🇧🇷🧠
Check out all our presentations here: https://t.co/rqZpYLSmUr
@alzassociation
Pesquisa importante feita pelo amigo @erzimmer e seu grupo de pesquisa mostra a relação da escolaridade c/ os processos de demência no caso brasileiro. Dado o envelhecimento da população, a compreensão do problema e a elaboração de políticas públicas são chaves para nosso futuro.
🎉 Congratulations to our PhD student @giovannacollar for receiving the AAIC Neuroscience Next ‘One to Watch’ Award at #AAICNeuro 🇺🇸!
A well-deserved recognition by the @alzassociation for her contributions to neuroscience research. 👏✨
🚨 New Study just out in @LancetGH 🧠 @lucasudaros, @vbwyll, @crisaguzzoli & colleagues used a machine learning model to determine the most important risk factors for cognitive and functional decline in Brazil and other Latin American Countries 🧶1👇 https://t.co/5vlWj2uYLx
🚨 Check out our recent study on @GreenJournal 🧠 @andreibieger & colleagues developed an algorithm to compare the outcomes of different Alzheimer’s disease diagnostic criteria in the same group of individuals 🪢👇 https://t.co/spJGlp0pp1
🚨 Don’t miss the upcoming @alzassociation#AAIC events in Latin America!
🧠 Neuroscience Next in Porto Alegre 🇧🇷 Buenos Aires 🇦🇷 and Santiago 🇨🇱
👉 Register now: https://t.co/d56SFnKM3a
🛰️ Satellite Symposium in Lima 🇵🇪
🗓️ Save the date – registration coming soon!
🚨 New Study Alert out in @alzdemjournals! In our latest publication, led by @guilhermepovala and #MarcoDeBastiani, we present a modular-oriented transcriptomic integration approach combined with neuroimaging to uncover novel insights into AD pathology👇🧶https://t.co/nTcVGBdWbK
Congratulations to @giovannacollar on receiving the Best Student Poster Award at #AAIC24! Her work on a polymorphism in RELN that protects against amyloid-driven tau pathology and cognitive decline in sporadic AD is impressive and well-deserved. What a fantastic ending ✨
We are pleased to be presenting the following works at #AAIC24@alzassociation coming up from July 27-Aug 1 in Philadelphia! We look forward to interacting with attendees at the conference.
Many thanks to @rigonfr for this graphic!
Check out the AAIC Neuroscience Next Porto Alegre Hub 2024 video. The POA Hub focuses on promoting diversity within Latin America.
Thank you, @alzassociation and @ISTAART!
https://t.co/0cseud2tYH
Last week, the @congressobrain Congress on Brain, Behavior and Emotions 2024 took place in Rio de Janeiro, and our team was in attendance. 🧠
Here are some highlights from our participation! @erzimmer@vbwyll@joanasenger@jpfsouza33
Projeto da UFRGS é contemplado na chamada do Instituto Serrapilheira. Proposta do Departamento de Farmacologia (ICBS) visa elucidar qual a origem celular da perda de volume cerebral relacionada à idade.
https://t.co/4eApaEeXKT
Foto: Gerry Shaw / CC BY-SA 3.0 Wikimédia Commons